Ftse Mib
33.674,33
1,37%
DAX
18.254,18
1,03%
S&P 500
5.473,17
-0,25%
NASDAQ
17.721,59
-0,79%
Bitcoin
65.040,44
0,11%
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Leap Therapeutics Inc (LPTX) Leap Therapeutics Inc (LPTX) Notizie

Leap Therapeutics Inc

LPTX
1,96
0,02 (1,03%)
Dopo l'orario di negoziazione
Ultimo aggiornamento: 22:30:00
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
24/5/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
23/5/202422:25EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
13/5/202413:10EDGAR2Form 8-K - Current report
13/5/202413:00PRNUSLeap Therapeutics Reports First Quarter 2024 Financial..
13/5/202412:50EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/5/202423:01EDGAR2Form S-3 - Registration statement under Securities Act of..
11/4/202414:30PRNUSLeap Therapeutics Announces $40 Million Private Placement
18/3/202412:00PRNUSLeap Therapeutics Reports Fourth Quarter and Full Year 2023..
01/2/202403:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/2/202403:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/2/202403:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/2/202403:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/2/202403:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/2/202403:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/2/202403:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/2/202403:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202402:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202402:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/1/202423:21EDGAR2Form S-8 - Securities to be offered to employees in employee..
23/1/202423:28EDGAR2Form 8-K - Current report
16/1/202423:10EDGAR2Form 8-K - Current report
16/1/202423:05PRNUSLeap Therapeutics to Present New Clinical Data from Part A..
03/1/202413:00PRNUSLeap Therapeutics to Participate at the 42nd Annual J.P...
02/1/202413:00PRNUSLeap Therapeutics Announces Completion of Enrollment in..
12/12/202322:02EDGAR2Form 8-K - Current report
11/12/202322:05PRNUSLeap Therapeutics to Present New Data from Part A of the..
21/11/202313:00PRNUSLeap Therapeutics to Participate at Piper Sandler 35th..
13/11/202313:10EDGAR2Form 8-K - Current report
13/11/202313:00PRNUSLeap Therapeutics Reports Third Quarter 2023 Financial..
13/11/202312:51EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/9/202320:44EDGAR2Form 8-K - Current report
05/9/202313:00PRNUSLeap Therapeutics to Participate at Upcoming Investor..
30/8/202322:30EDGAR2Form S-8 - Securities to be offered to employees in employee..
25/8/202322:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/8/202322:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/8/202322:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/8/202322:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/8/202322:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/8/202322:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/8/202322:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/8/202322:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/8/202313:10EDGAR2Form 8-K - Current report
14/8/202313:00PRNUSLeap Therapeutics Reports Second Quarter 2023 Financial..
14/8/202312:50EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
12/7/202313:10EDGAR2Form 8-K - Current report
12/7/202313:00PRNUSLeap Therapeutics Announces Initiation of Randomized..
Apertura: 1,93 Min: 1,93 Max: 2,01
Chiusura: 1,94

La tua Cronologia

NASDAQ
LPTX
Leap Therapeutics
BOV
MLAS3F
Multilaser Industrial ON
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network